HighTower Advisors »

Amneal Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $103k 12k 8.45
2024-06-30 $82k 13k 6.21

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl A (GOOGL)
Sharkninja Com Shs (SN)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for HighTower Advisors

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Tpg Gp A
Rubric Capital Management
Citadel Advisors
Dimensional Fund Advisors
Geode Capital Management
Neuberger Berman Group
State Street Corporation
Nantahala Capital Management
Nuveen Asset Management
BlackBarn Capital Partners
Invesco
Northern Trust
Acadian Asset Management

View all funds holding Amneal Pharmaceuticals